These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19090933)

  • 1. Advances in antiplatelet therapy for ACS and PCI.
    Moliterno DJ
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S18-24. PubMed ID: 19090933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiplatelet agents: why they are needed.
    Franchini M; Mannucci PM
    Eur J Intern Med; 2009 Dec; 20(8):733-8. PubMed ID: 19892299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
    Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
    Steinhubl SR
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S12-9. PubMed ID: 17224886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical overview of promising nonthienopyridine antiplatelet agents.
    Angiolillo DJ; Guzman LA
    Am Heart J; 2008 Aug; 156(2 Suppl):S23-8. PubMed ID: 18657683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions.
    Becker RC; Gibson CM; Jennings LK; Morrow DA
    Am J Cardiol; 2010 Oct; 106(8):S2-3. PubMed ID: 20920638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging antithrombotic drugs for acute coronary syndrome.
    Shimada YJ; Giugliano RP
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):307-18. PubMed ID: 23848430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
    Cross J
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cangrelor: a novel P2Y12 receptor antagonist.
    Norgard NB
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1219-30. PubMed ID: 19604122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new generation of antiplatelet agents.
    Sellers MB; Tricoci P; Harrington RA
    Curr Opin Cardiol; 2009 Jul; 24(4):307-12. PubMed ID: 19509485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
    Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
    Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on antiplatelet therapy in acute coronary syndromes: what do new drugs bring into clinical practice?
    Heras M; del Río A
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():13-7. PubMed ID: 20000883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
    Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
    Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in antiplatelet therapy for acute coronary syndromes and considerations for long-term management.
    Cowley MJ; Kuritzky L
    Curr Med Res Opin; 2009 Jun; 25(6):1477-90. PubMed ID: 19419337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
    Umman B
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet P2 receptors: old and new targets for antithrombotic drugs.
    Cattaneo M
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):45-55. PubMed ID: 17187456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.
    TRA*CER Executive and Steering Committees
    Am Heart J; 2009 Sep; 158(3):327-334.e4. PubMed ID: 19699853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.